Insights

Clinical-stage opportunity ZielBio is a clinical-stage biotechnology company focused on cancer therapeutics, indicating a current need for strategic partnerships, CRO coordination, and potential licensing discussions to advance trials and clinical development.

Leadership change Appointment of Alan S. Bash as CEO signals potential shifts in strategic direction, storytelling for investors, and new business development outreach to align with leadership priorities and broaden collaboration opportunities.

Funding momentum Past Series A funding and ongoing development with a $33M funding base suggest capacity for external collaborations, co-development deals, and early access licensing discussions with larger biotech or pharma partners.

Cancer focus Concentration on identifying druggable targets and expanding cancer therapeutics positions ZielBio for partnerships around precision oncology, biomarker capabilities, and companion diagnostic opportunities.

Growth profile Modest headcount with a high-value biotech focus implies potential engagement for technology licensing, R&D collaboration, clinical research support, and strategic alliances to accelerate pipeline milestones.

ZielBio, Inc. Tech Stack

ZielBio, Inc. uses 8 technology products and services including WordPress, Shopify, Microsoft 365, and more. Explore ZielBio, Inc.'s tech stack below.

WordPress

Content Management System

Shopify

E-commerce

Microsoft 365

Google Cloud

Infrastructure As A Service

WP Engine

Platform As A Service

Yoast SEO

Search Engines

Google Analytics

Web Analytics

Nginx

Web Servers

ZielBio, Inc. Email Formats	Example	Percentage
FLast@zielbio.com	JDoe@zielbio.com	100%

ZielBio, Inc. Email Formats

Example

Percentage

FLast@zielbio.com

JDoe@zielbio.com

100%

Frequently Asked Questions

What is ZielBio, Inc.'s official website and social media links?

ZielBio, Inc.'s official website is zielbio.com and has social profiles on LinkedIn.

How much revenue does ZielBio, Inc. generate?

As of July 2026, ZielBio, Inc.'s annual revenue is estimated to be <$1M.

What is ZielBio, Inc.'s SIC code and NAICS code?

ZielBio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ZielBio, Inc. have currently?

As of July 2026, ZielBio, Inc. has approximately 13 employees across 1 continents, including North America. Key team members include Chief Executive Officer: G. K. Explore ZielBio, Inc.'s employee directory with LeadIQ.

What industry does ZielBio, Inc. belong to?

ZielBio, Inc. operates in the Biotechnology industry.

What technology does ZielBio, Inc. use?

ZielBio, Inc.'s tech stack includes WordPress, Shopify, Microsoft 365, Google Cloud, WP Engine, Yoast SEO, Google Analytics and Nginx.

What is ZielBio, Inc.'s email format?

ZielBio, Inc.'s email format typically follows the pattern of FLast@zielbio.com. Find more ZielBio, Inc. email formats with LeadIQ.

How much funding has ZielBio, Inc. raised to date?

As of July 2026, ZielBio, Inc. has raised $33M in funding. The last funding round occurred on Sep 27, 2022.

When was ZielBio, Inc. founded?

ZielBio, Inc. was founded in 2010.

ZielBio, Inc.

Q: What is ZielBio, Inc.'s official website and social media links?

ZielBio, Inc.'s official website is zielbio.com. ZielBio, Inc. has social profiles on LinkedIn.

Q: How many employees does ZielBio, Inc. have currently?

ZielBio, Inc. has approximately 13 employees.

Q: What industry does ZielBio, Inc. belong to?

ZielBio, Inc. operates in the Biotechnology industry.

Q: What technology does ZielBio, Inc. use?

ZielBio, Inc.'s tech stack includes Yoast SEO, RSS, Priority Hints, PHP, GoDaddy Website Builder.

Q: How much funding has ZielBio, Inc. raised to date?

ZielBio, Inc. has raised $33M in funding. The last funding round occurred on Sep 27, 2022.

Q: When was ZielBio, Inc. founded?

ZielBio, Inc. was founded in 2010.

Q: What is ZielBio, Inc.'s NAICS code?

ZielBio, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

BiotechnologyVirginia, United States11-50 Employees

ZielBio, Inc. is a clinical-stage biotechnology company focused on discovering and developing targeted cancer therapies. It employs a technology platform to identify disease-relevant, druggable targets with the potential to improve how cancer is treated. The company is advancing several therapeutic candidates to broaden treatment options for patients with cancer.

Based in Charlottesville, Virginia, ZielBio belongs to the biotechnology research sector and positions itself as a developer of oncology therapeutics. As a small to mid-sized organization, it engages with the clinical community and patients to pursue more precise and effective cancer care. In early 2023, the company appointed Alan Bash as chief executive officer and board member, signaling leadership evolution as it progresses its oncology programs.

Insights

Similar companies to ZielBio, Inc.

Xencor

ADC Therapeutics

ZielBio, Inc. Tech Stack

Media & News

ZielBio, Inc. hires Alan as CEO.

ZielBio, Inc. hired Alan S. Bash as Chief Executive Officer and member of the company's Board of Directors on Jan 3rd '23.

Morningside Ventures invested into ZielBio, Inc. $25M on Jan 1st '19.

ZielBio, Inc. received financing of $25M in Series A on Jan 1st '19.

ZielBio, Inc. hires Dieter Weinand as Executive Chair.

ZielBio, Inc.'s Email Address Formats